4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000066
President, Research & Develop. sold 4,109 shares at an average $20.03 ($82,300)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2024-11-11 | Sale 10b5-1 | −1,409 | $20.01 | $28,191 | 163,588 | D: show line 1 in the form |
| Sethuraman Natarajan President, Research & Develop. | 2024-11-13 | Sale 10b5-1 | −2,700 | $20.04 | $54,109 | 160,888 | D: show line 2 in the form |
| Open-market sales · 4,109 sh · avg $20.03 · $82,300 | |||||||
Loading xslF345X05/wk-form4_1731534539.xml…